Guanxin V for coronary artery disease: a randomized controlled trial
Phase 1
- Conditions
- coronary artery disease
- Registration Number
- ITMCTR2000003194
- Lead Sponsor
- anjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Adults.
2. Meet the diagnostic criteria of CAD.
3. Meet the diagnostic criteria of Qi and Yin deficiency and blood stasis.
Exclusion Criteria
1. Continuation of any form of Chinese herbal medicines for 14 days before enrollment.
2. Be allergic to test ingredients or accessories.
3. The pregnant and lactating women and women planning pregnancy for nearly six months.
4. Individuals participating in other clinical trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Traditional Chinese medicine syndrome score;Heart function;
- Secondary Outcome Measures
Name Time Method 6MWT;CO;SV;LVEF;NT-pro BNP;